Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

EGFR Amplification as a Target in Gastroesophageal Adenocarcinoma: Do Anti-EGFR Therapies Deserve a Second Chance?

Strickler JH.

Cancer Discov. 2018 Jun;8(6):679-681. doi: 10.1158/2159-8290.CD-18-0191.

PMID:
29858225
2.

A phase 1 dose-escalation study of veliparib with bimonthly FOLFIRI in patients with advanced solid tumours.

Berlin J, Ramanathan RK, Strickler JH, Subramaniam DS, Marshall J, Kang YK, Hetman R, Dudley MW, Zeng J, Nickner C, Xiong H, Komarnitsky P, Shepherd SP, Hurwitz H, Lenz HJ.

Br J Cancer. 2018 Apr;118(7):938-946. doi: 10.1038/s41416-018-0003-3. Epub 2018 Mar 12.

PMID:
29527010
3.

Genomic Landscape of Cell-Free DNA in Patients with Colorectal Cancer.

Strickler JH, Loree JM, Ahronian LG, Parikh AR, Niedzwiecki D, Pereira AAL, McKinney M, Korn WM, Atreya CE, Banks KC, Nagy RJ, Meric-Bernstam F, Lanman RB, Talasaz A, Tsigelny IF, Corcoran RB, Kopetz S.

Cancer Discov. 2018 Feb;8(2):164-173. doi: 10.1158/2159-8290.CD-17-1009. Epub 2017 Dec 1.

PMID:
29196463
4.

Targeting BRAF in metastatic colorectal cancer: Maximizing molecular approaches.

Strickler JH, Wu C, Bekaii-Saab T.

Cancer Treat Rev. 2017 Nov;60:109-119. doi: 10.1016/j.ctrv.2017.08.006. Epub 2017 Aug 31. Review.

5.

Evaluation of the pharmacokinetic drug interaction potential of tivantinib (ARQ 197) using cocktail probes in patients with advanced solid tumours.

Tachibana M, Papadopoulos KP, Strickler JH, Puzanov I, Gajee R, Wang Y, Zahir H.

Br J Clin Pharmacol. 2018 Jan;84(1):112-121. doi: 10.1111/bcp.13424. Epub 2017 Oct 29.

PMID:
28865153
6.

Clinical applications of liquid biopsies in gastrointestinal oncology.

Zhu J, Strickler JH.

J Gastrointest Oncol. 2016 Oct;7(5):675-686. Review.

7.

Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

Balaban EP, Mangu PB, Khorana AA, Shah MA, Mukherjee S, Crane CH, Javle MM, Eads JR, Allen P, Ko AH, Engebretson A, Herman JM, Strickler JH, Benson AB 3rd, Urba S, Yee NS.

J Clin Oncol. 2016 Aug 1;34(22):2654-68. doi: 10.1200/JCO.2016.67.5561. Epub 2016 May 31.

PMID:
27247216
8.

Development of a Novel c-MET-Based CTC Detection Platform.

Zhang T, Boominathan R, Foulk B, Rao C, Kemeny G, Strickler JH, Abbruzzese JL, Harrison MR, Hsu DS, Healy P, Li J, Pi C, Prendergast KM, Hobbs C, Gemberling S, George DJ, Hurwitz HI, Connelly M, Garcia-Blanco MA, Armstrong AJ.

Mol Cancer Res. 2016 Jun;14(6):539-47. doi: 10.1158/1541-7786.MCR-16-0011. Epub 2016 Mar 7.

9.

Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome.

Roe MT, Cyr DD, Eckart D, Schulte PJ, Morse MA, Blackwell KL, Ready NE, Zafar SY, Beaven AW, Strickler JH, Onken JE, Winters KJ, Houterloot L, Zamoryakhin D, Wiviott SD, White HD, Prabhakaran D, Fox KA, Armstrong PW, Ohman EM; TRILOGY ACS Investigators.

Eur Heart J. 2016 Jan 21;37(4):412-22. doi: 10.1093/eurheartj/ehv611. Epub 2015 Dec 5.

10.

Treatment of High-Grade Metastatic Pancreatic Neuroendocrine Carcinoma with FOLFIRINOX.

Zhu J, Strosberg JR, Dropkin E, Strickler JH.

J Gastrointest Cancer. 2015 Jun;46(2):166-9. doi: 10.1007/s12029-015-9689-0. No abstract available.

PMID:
25662891
11.

Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors.

Rangwala F, Bendell JC, Kozloff MF, Arrowood CC, Dellinger A, Meadows J, Tourt-Uhlig S, Murphy J, Meadows KL, Starr A, Broderick S, Brady JC, Cushman SM, Morse MA, Uronis HE, Hsu SD, Zafar SY, Wallace J, Starodub AN, Strickler JH, Pang H, Nixon AB, Hurwitz HI.

Invest New Drugs. 2014 Aug;32(4):700-9. doi: 10.1007/s10637-014-0089-2. Epub 2014 Apr 9.

12.

Gastroesophageal heterotopia and HER2/neu overexpression in an adenocarcinoma arising from a small bowel duplication.

Nussbaum DP, Bhattacharya SD, Jiang X, Cardona DM, Strickler JH, Blazer DG 3rd.

Arch Pathol Lab Med. 2014 Mar;138(3):428-31. doi: 10.5858/arpa.2012-0523-CR.

PMID:
24576036
13.

Palliative treatment of metastatic colorectal cancer: what is the optimal approach?

Strickler JH, Hurwitz HI.

Curr Oncol Rep. 2014;16(1):363. doi: 10.1007/s11912-013-0363-z. Review.

PMID:
24293074
14.

Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer.

Strickler JH, McCall S, Nixon AB, Brady JC, Pang H, Rushing C, Cohn A, Starodub A, Arrowood C, Haley S, Meadows KL, Morse MA, Uronis HE, Blobe GC, Hsu SD, Zafar SY, Hurwitz HI.

Invest New Drugs. 2014 Apr;32(2):330-9. doi: 10.1007/s10637-013-0042-9. Epub 2013 Nov 1.

15.

Phase I study of bevacizumab, everolimus, and panobinostat (LBH-589) in advanced solid tumors.

Strickler JH, Starodub AN, Jia J, Meadows KL, Nixon AB, Dellinger A, Morse MA, Uronis HE, Marcom PK, Zafar SY, Haley ST, Hurwitz HI.

Cancer Chemother Pharmacol. 2012 Aug;70(2):251-8. doi: 10.1007/s00280-012-1911-1. Epub 2012 Jun 29.

16.

Bevacizumab-based therapies in the first-line treatment of metastatic colorectal cancer.

Strickler JH, Hurwitz HI.

Oncologist. 2012;17(4):513-24. doi: 10.1634/theoncologist.2012-0003. Epub 2012 Apr 3. Review.

17.

Maintenance therapy for first-line metastatic colorectal cancer: activity and sustainability.

Strickler JH, Hurwitz HI.

Oncologist. 2012;17(1):9-10. doi: 10.1634/theoncologist.2011-0358. Epub 2012 Jan 10. No abstract available.

19.

Three-dimensional optical data storage in refractive media by two-photon point excitation.

Strickler JH, Webb WW.

Opt Lett. 1991 Nov 15;16(22):1780-2.

PMID:
19784138
20.

Two-photon laser scanning fluorescence microscopy.

Denk W, Strickler JH, Webb WW.

Science. 1990 Apr 6;248(4951):73-6.

PMID:
2321027
21.

How many surgeons are needed?

Strickler JH.

Minn Med. 1968 Mar;51(3):331. No abstract available.

PMID:
5649327
22.

Pseudomembranous enterocolitis. A comparison with staphylococcal colitis.

Strickler JH, Rice CO.

Minn Med. 1966 Jun;49(6):899-904. No abstract available.

PMID:
5933702
23.

BREAST PAPILLOMATOSIS.

STRICKLER JH.

Minn Med. 1964 Oct;47:1253-4. No abstract available.

PMID:
14252363
24.

Diagnostic paracentesis.

STRICKLER JH, ERWIN PD, RICE CO.

AMA Arch Surg. 1958 Dec;77(6):859-63. No abstract available.

PMID:
13593980
25.

Fluid, electrolyte and nutritional requirements in the average surgical patient: a statistical analysis.

RICE CO, STRICKLER JH.

Minn Med. 1958 Aug;41(8):557-62. No abstract available.

PMID:
13577635
26.

A statistical analysis of the fluid and electrolyte requirements of surgical patients.

RICE CO, STRICKLER JH, WECKWERTH V.

Am J Surg. 1957 Nov;94(5):727-9. No abstract available.

PMID:
13470169
27.

A day by day analysis of the fluid, electrolyte and nitrogen metabolism as it pertains to parenteral feeding.

RICE CO, STRICKLER JH, WECKWERTH V.

Am J Surg. 1957 Jul;94(1):35-8. No abstract available.

PMID:
13424867
28.

Amino acid solutions for intravenous use; the reduced incidence of systemic reactions when using a low glutamic acid mixture.

RICE CO, STRICKLER JH.

Am J Clin Nutr. 1957 Jan-Feb;5(1):11-3. No abstract available.

PMID:
13394533
29.

The relationship of an elevated blood sugar to an electrolyte imbalance.

RICE CO, STRICKLER JH, AZERIS H.

AMA Arch Surg. 1956 Mar;72(3):508-13. No abstract available.

PMID:
13291979
30.
31.

Parenteral nutrition in surgery.

RICE CO, STRICKLER JH.

SD J Med Pharm. 1956 Jan;9(1):1-7. No abstract available.

PMID:
13290945
32.

Lower nephron nephrosis. II. The function of the kidney when tubular degeneration exists.

RICE CO, STRICKLER JH.

Am J Surg. 1955 Oct;90(4):558-61. No abstract available.

PMID:
13258946
33.

Lower nephron nephrosis. I. A pathogenesis for degeneration of the kidney tubules.

RICE CO, STRICKLER JH, LUFKIN N.

Am J Surg. 1955 Oct;90(4):547-57. No abstract available.

PMID:
13258945
34.

Hyperpotassemia and hyperglycemia; treatment with insulin and invert sugar.

RICE CO, STRICKLER JH.

Minn Med. 1955 Aug;38(8):565-7. No abstract available.

PMID:
13244542
35.

Clinical aspects of fluid and electrolyte management.

STRICKLER JH, RICE CO.

Minn Med. 1955 Mar;38(3):153-64. No abstract available.

PMID:
14369926
36.

Ether flush treatment of retained postoperative common duct stones; a local survey.

STRICKLER JH, ADKINS DC, RICE CO.

Minn Med. 1954 Jul;37(7):490-7. No abstract available.

PMID:
13185168
37.

Degeneration of the kidney tubules (lower nephron nephrosis) associated with electrolyte imbalance; preliminary report.

RICE CO, STRICKLER JH, FERNANDEZ G, LUFKIN N.

Minn Med. 1954 Jun;37(6):421-5. No abstract available.

PMID:
13165371
38.

Parenteral nutrition; adequate parenteral nutrition in general surgery.

RICE CO, STRICKLER JH.

Med Times. 1953 May;81(5):307-14. No abstract available.

PMID:
13054082
39.

Use of polyethylene tubing in intravenous therapy for surgical patients.

ERWIN P, STRICKLER JH, RICE CO.

AMA Arch Surg. 1953 May;66(5):673-8. No abstract available.

PMID:
13039740
40.

An approach toward the ideal in parenteral nutrition.

STRICKLER JH, RICE CO.

Minn Med. 1953 Mar;36(3):221-9. No abstract available.

PMID:
13036782
41.

Parenteral nutrition in elderly surgical patients.

RICE CO, STRICKLER JH.

Geriatrics. 1952 Jul-Aug;7(4):232-40. No abstract available.

PMID:
12980317
42.

Hepatic portal arteriovenous fistula; a case report.

STRICKLER JH, LUFKIN N, RICE CO.

Surgery. 1952 Apr;31(4):583-9. No abstract available.

PMID:
14922105
43.

The problems of parenteral nutrition in the surgical patient.

RICE CO, STRICKLER JH.

J Indiana State Med Assoc. 1952 Feb;45(2):122-30. No abstract available.

PMID:
14908130
44.

Value of parenteral nutrition in the poor risk surgical patient.

RICE CO, BAUER P, STRICKLER JH.

Am J Surg. 1952 Jan;83(1):50-4. No abstract available.

PMID:
14903328
45.

Parenteral nutrition with a solution containing one thousand calories per liter.

RICE CO, STRICKLER JH, ERWIN PD.

AMA Arch Surg. 1952 Jan;64(1):20-7. No abstract available.

PMID:
14877396
46.

Adeno-mammectomy for benign breast lesions.

RICE CO, STRICKLER JH.

Surg Gynecol Obstet. 1951 Dec;93(6):759-62. No abstract available.

PMID:
14893082
47.

Nonoperative treatment of retained postoperative common duct stones.

STRICKLER JH, MULLER JJ, RICE CO, BARONOFSKY ID.

Ann Surg. 1951 Feb;133(2):174-83. No abstract available.

48.

Parenteral nutrition in surgery. Significance of calories and protein in maintaining a positive nitrogen balance.

RICE CO, ORR B, TRELOAR AE, STRICKLER JH.

AMA Arch Surg. 1950 Dec;61(6):977-91. No abstract available.

PMID:
14777231
49.

Non-operative decompression of the intestinal distention of bowel obstruction and related diseases.

STRICKLER JH.

Minn Med. 1949 Mar;32(3):304-8. No abstract available.

PMID:
18125263
50.

The rationale of eliminating starvation postoperatively.

RICE CO, STRICKLER JH, ORR BA.

Minn Med. 1948 May;31(5):550-3. No abstract available.

PMID:
18862583

Supplemental Content

Loading ...
Support Center